Anti-P2RX6/ P2RXL1/ P2X6 monoclonal antibody

Anti-P2RX6/ P2RXL1/ P2X6 antibody for FACS & in-vivo assay

Target products collectionGo to P2RX6/P2RX6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1309-Ab-1/ GM-Tg-hg-MP1309-Ab-2Anti-Human P2RX6 monoclonal antibodyHuman
GM-Tg-rg-MP1309-Ab-1/ GM-Tg-rg-MP1309-Ab-2Anti-Rat P2RX6 monoclonal antibodyRat
GM-Tg-mg-MP1309-Ab-1/ GM-Tg-mg-MP1309-Ab-2Anti-Mouse P2RX6 monoclonal antibodyMouse
GM-Tg-cynog-MP1309-Ab-1/ GM-Tg-cynog-MP1309-Ab-2Anti-Cynomolgus/ Rhesus macaque P2RX6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1309-Ab-1/ GM-Tg-felg-MP1309-Ab-2Anti-Feline P2RX6 monoclonal antibodyFeline
GM-Tg-cang-MP1309-Ab-1/ GM-Tg-cang-MP1309-Ab-2Anti-Canine P2RX6 monoclonal antibodyCanine
GM-Tg-bovg-MP1309-Ab-1/ GM-Tg-bovg-MP1309-Ab-2Anti-Bovine P2RX6 monoclonal antibodyBovine
GM-Tg-equg-MP1309-Ab-1/ GM-Tg-equg-MP1309-Ab-2Anti-Equine P2RX6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1309-Ab-1/ GM-Tg-hg-MP1309-Ab-2; GM-Tg-rg-MP1309-Ab-1/ GM-Tg-rg-MP1309-Ab-2;
GM-Tg-mg-MP1309-Ab-1/ GM-Tg-mg-MP1309-Ab-2; GM-Tg-cynog-MP1309-Ab-1/ GM-Tg-cynog-MP1309-Ab-2;
GM-Tg-felg-MP1309-Ab-1/ GM-Tg-felg-MP1309-Ab-2; GM-Tg-cang-MP1309-Ab-1/ GM-Tg-cang-MP1309-Ab-2;
GM-Tg-bovg-MP1309-Ab-1/ GM-Tg-bovg-MP1309-Ab-2; GM-Tg-equg-MP1309-Ab-1/ GM-Tg-equg-MP1309-Ab-2
Products NameAnti-P2RX6 monoclonal antibody
Formatmab
Target NameP2RX6
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-P2RX6 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species P2RX6/ P2RXL1/ P2X6 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1309
    Target NameP2RX6
    Gene ID9127,18440,25041,695841,618262,100051842
    Gene Symbol and SynonymsP2RX6,P2RXL1,P2X6,P2XM,Rnap2x6
    Uniprot AccessionO15547,P51579
    Uniprot Entry NameP2RX6_HUMAN,P2RX6_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000099957
    Target ClassificationN/A

    The target: P2RX6, gene name: P2RX6, also named as P2RXL1, P2X6, P2XM. The protein encoded by this gene belongs to the family of P2X receptors, which are ATP-gated ion channels and mediate rapid and selective permeability to cations. This gene is predominantly expressed in skeletal muscle, and regulated by p53. The encoded protein is associated with VE-cadherin at the adherens junctions of human umbilical vein endothelial cells. Alternative splicing results in multiple transcript variants. A related pseudogene, which is also located on chromosome 22, has been identified. [provided by RefSeq, Apr 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.